MedTech Dive3d
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Yahoo Finance9d
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter
DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Drug Delivery Business5d
Insulet expands Omnipod 5 to more countries, prices $450M offering
Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...
BMJ20d
Feasibility of continuous glucose monitoring in patients with type 1 diabetes at two district hospitals in Neno, Malawi: a randomised controlled trial
Interventions Participants were randomly assigned to Dexcom G6 CGM (n=30) use or usual care (UC ... Results Participants tolerated CGM well but were unable to change their own sensors which resulted ...